Radiopharmaceutical Batch Dilution for Matched Activity Timing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing radiopharmaceuticals face challenges in maintaining consistent radioactivity and composition across multiple applications due to the short half-life of radionuclides, leading to complex and costly production processes that either require frequent reconstitution on-site or limited availability to users.
Innovation Solution
A method and apparatus using a radionuclide-containing concentrate to produce batches with identical activity at different times, involving a fluidic system with adjustable components to dilute bulk solutions, ensuring consistent radioactivity across multiple applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If radiopharmaceuticals are produced frequently on-site due to short half-life, then availability is improved, but manufacturing complexity and cost increase
Solution Approach 1:
The patent applies preliminary action by producing a bulk solution with standardized activity at a reference time point before actual use. This bulk solution is prepared in advance and stored, allowing multiple subsequent applications without requiring complex on-site production processes. The bulk solution serves as a pre-prepared resource that simplifies downstream operations.
Solution Approach 2:
The patent utilizes parameter changes by adjusting the activity concentration of the bulk solution through controlled dilution. By changing the concentration parameter while maintaining standardized activity at the reference time, the system can serve multiple applications with different timing requirements without increasing manufacturing complexity.
2Adaptability or versatility
If bulk solutions are diluted to match different activity levels, then adaptability to different application times is improved, but manufacturing precision requirements increase
Solution Approach 1:
The patent introduces a diluting solution as an intermediary substance that enables flexible adjustment of activity levels. This intermediary allows the bulk solution to be adapted to different application times without requiring precise direct calibration for each specific application, thereby reducing the precision burden on the main manufacturing process.
Solution Approach 2:
The patent applies parameter changes by using controlled dilution to adjust the activity concentration parameter. This allows a single bulk solution to be adapted to multiple different application times and activity requirements while maintaining traceability to the standardized reference time calibration, thus achieving versatility without proportionally increasing precision requirements.
3Productivity
If multiple batches are produced for different times, then availability is improved, but quality control costs increase
Solution Approach 1:
The patent applies universality by creating a single bulk solution that serves multiple functions for different application times. Instead of producing separate batches for each time point, the standardized bulk solution can be diluted and used for multiple applications, thereby reducing the total number of batches that require quality control and lowering overall quality control costs.
Solution Approach 2:
The patent merges multiple potential production batches into a single standardized bulk solution. By combining the production process into one unified operation that yields a versatile bulk solution, the system reduces the cumulative quality control burden that would otherwise apply to multiple separate batches produced for different times.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient, cost-effective production of radiopharmaceuticals with consistent activity and composition at various times, reducing manufacturing and quality control costs while maintaining high quality and availability.
Implementation Method 1
the remaining bulk solution set to the latest desired time of application (ART+4) is diluted with the diluting solution in such a way that, at the time of filling, a desired reduced activity based on the latest time of application (ART+4) is set
Implementation Method 2
a radionuclide-containing concentrate is provided which contains the desired radionuclide in such an activity that a plurality of desired batches, each with a defined number of partial fillings, can be obtained from the concentrate at a filling time, each batch of partial fillings at different times of application (ART+1, ART+2, ART+3, ART+4) in each case substantially having an identical activity of the radionuclide, with respect to the calibration time (ART)
Data Source
AI summary
A method and an apparatus for producing radionuclide-containing products having substantially the identical desired activity of radioactivity at different times of application, with respect to a given calibration time. The method according to the invention allows to ensure a consistent composition of the desired radionuclide-labeled pharmaceutical at all times of application within the shelf life through a single manufacturing process. With the present invention it is possible, for example, to provide [n.c.a. Lu-177]Lu-DOTATOC on each working day of the week with constant activity at the respective time of application in a single manufacturing step.


